person

Miriam J. Z.

Country
Norway
Department
..

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 10 partner sites.

Specializations

Metabolic Liver Disease

Focused on progressive liver conditions linked to metabolic dysfunction, particularly the fibrotic spectrum of fatty liver disease.

  • Non-Alcoholic Steatohepatitis (NASH)
  • Non-Alcoholic Fatty Liver Disease (NAFLD)
  • Liver fibrosis

Research integrates metabolic risk factors such as obesity and type 2 diabetes to explore disease mechanisms and therapeutic targets.

Cardiovascular & Metabolic Risk

Investigates atherosclerotic disease and arrhythmias in the context of systemic metabolic disturbances.

  • Atherosclerotic Cardiovascular Disease (ASCVD)
  • Atrial fibrillation
  • Hypertension
  • Type 2 diabetes

Emphasis is placed on prevention of ischemic events and optimization of anticoagulation strategies in high‑risk populations.

Oncology

Broad engagement with solid tumors and hematologic malignancies, emphasizing precision oncology and novel therapeutic combinations.

  • Breast cancer
  • Non‑Small Cell Lung Cancer
  • Prostate cancer
  • Multiple Myeloma
  • Acute Myeloid Leukemia (AML)
  • Colorectal cancer

Studies address disease‑specific biomarkers, resistance mechanisms, and outcomes across early‑stage and metastatic settings.

Neurology & Neurodegeneration

Targets neurodegenerative and neurovascular disorders, with a focus on cognitive decline and chronic pain syndromes.

  • Alzheimer’s disease
  • Amyotrophic Lateral Sclerosis (ALS)
  • Migraine
  • Stroke
  • Multiple Sclerosis

Research includes evaluation of disease‑modifying agents and symptom‑relief strategies.

Immunology & Pulmonary Medicine

Explores immune‑mediated inflammatory diseases affecting the lungs and other organ systems.

  • Idiopathic Pulmonary Fibrosis (IPF)
  • Active Pulmonary Sarcoidosis
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Primary Sclerosing Cholangitis (PSC)
  • Inflammatory Bowel Disease (IBD)

Efforts aim to delineate pathogenic pathways and assess targeted immunotherapies.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.